MeNow Overview
MeNow develops chemoinformatics using artificial intelligence to predict the effect of cosmetic ingredients on a virtual model of the user’s skin. The company’s solutions enable data integration and better understanding of the molecular structure of products in order to improve skin health worldwide. MeNow is focused on designing better cosmetic formulations and providing a platform for personalized recommendations to help ensure that every product respects the user’s particular skin biology.
Latest News
growth-positive
Green Mountain Biotech and MeNow Announce Collaboration for AI-Based Development of Skincare Products Based on Traditional Chinese Medicine
Green Mountain Biotech and MeNow have announced a collaboration for the AI-based development of skincare products based on traditional Chinese medicine. The companies are combining their expertise in artificial intelligence and Chinese medicinal plants to identify new plant combinations for treating a variety of skin conditions. During the project, medicinal plants from the Chinese pharmacopeia selected by Green Mountain Biotech scientists are being scanned using MeNows innovative algorithms to predict their effects on different skin conditions. The collaboration aims to develop and introduce new lines of innovative and potent dermocosmetic products to the market. This collaboration marks the beginning of a new era in the world of cosmetics, combining deep-learning technologies with traditional medicinal plants.
Partners
growth-positive
"Cosmetics have side effects that we can prevent by using AI" | CTech
MeNow, a company that assists online cosmetics retailers in matching the right products to their customers, is helping to prevent harmful side effects. The company uses AI to analyze medical data and real-world evidence to find the correct matches. This was revealed by Dr. Hilla Ben-Hamo, Co-founder and CEO of MeNow, during an interview at the Shufersal Online and Calcalist e-commerce event. She explained that manufacturers do not check how every product affects each individual, but MeNow can identify every molecule and its effect.
Customers
| Sector | Business Software |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 11-50
Web & Social Links
| Website | www.menow.ai |
Locations
Tel Aviv-Yafo, Israel
Photos & Videos
1 item(s)
MeNow Business
Business models
B2B
Product stage
—
Employees
11-50
Sector
Business SoftwareSales & Marketing Solutionse-Commerce ToolsTarget Customer
Healthcare & Life SciencesLife SciencesCosmeticsCore Technology
Artificial IntelligencePlatforms & InterfacesAPIMobileTags (6)
recommendationscustomer-experiencesalesartificial-intelligencecosmeticsskin-careMeNow Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Pre-Funding
Funding stage
0
Total rounds
0
Investors
MeNow Lifecycle
MeNow News
2 articles
growth-positive
Green Mountain Biotech and MeNow Announce Collaboration for AI-Based Development of Skincare Products Based on Traditional Chinese Medicine
Green Mountain Biotech and MeNow have announced a collaboration for the AI-based development of skincare products based on traditional Chinese medicine. The companies are combining their expertise in artificial intelligence and Chinese medicinal plants to identify new plant combinations for treating a variety of skin conditions. During the project, medicinal plants from the Chinese pharmacopeia selected by Green Mountain Biotech scientists are being scanned using MeNows innovative algorithms to predict their effects on different skin conditions. The collaboration aims to develop and introduce new lines of innovative and potent dermocosmetic products to the market. This collaboration marks the beginning of a new era in the world of cosmetics, combining deep-learning technologies with traditional medicinal plants.
Partners
growth-positive
"Cosmetics have side effects that we can prevent by using AI" | CTech
MeNow, a company that assists online cosmetics retailers in matching the right products to their customers, is helping to prevent harmful side effects. The company uses AI to analyze medical data and real-world evidence to find the correct matches. This was revealed by Dr. Hilla Ben-Hamo, Co-founder and CEO of MeNow, during an interview at the Shufersal Online and Calcalist e-commerce event. She explained that manufacturers do not check how every product affects each individual, but MeNow can identify every molecule and its effect.
Customers
MeNow Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 38 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
MeNow Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 81/100 |
| Missing | product stage, funding rounds, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516649951 |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2023-02-16T00:00:00.000Z |
| Created | 2023-02-15T00:00:00.000Z |